20/20 BIOLABS, INC. Shareholders' Equity
20/20 BIOLABS, INC. (AIDX) had Shareholders' Equity of $1.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.62M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.55M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$19.23K.
- 2025-06-30: Stockholders' Equity Attributable to Parent $351.61K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.62M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.55M 10-Q · filed 2026-08-14 |
| 2025-12-31 | -$19.23K 10-Q · filed 2026-08-14 |
| 2025-06-30 | $351.61K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $1.06M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $1.51M 10-Q · filed 2026-08-14 |
| 2023-12-31 | $4.29M POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |